Click an icon above to automatically deliver all podcasts to your iTunes or rich media player
LATEST PODCAST:
UPLC, QTof, HDMS, and more: A practical guide to the hottest techniques driving the future of biopharmaceutical science
Episode Number 3: Advances in glycan analysis In this podcast series, we?ll provide you with a firm knowledge of the latest technological innovations in LC and LC/MS that have been designed to address and advance the very specific needs of the many applications areas in the biopharmaceutical laboratory.
Listen>>>
Episode Number 2: Getting more specificity in host cell protein analysis using proteomics approaches In this podcast, we will introduce the capabilities added by the analysis of residual Host Cell Proteins by novel LC/MS techniques, providing more information on which an organization can act in this challenging application area.
Listen>>>
Episode Number 1: Current challenges in oligonucleotide analysis. Today we'll be discussing some of the primary analytical challenges faced by oligotherapeutic and oligodiagnostic manufacturers for characterizing and quantitating oligonucleotides. Listen>>>
RECENT PODCASTS:
FDA´s Keith Webber on Setting Specifications. He talks about how product specifications for biological products apply to individual samples or averages; the use of specifications vs. control limits; stability results, and more. Listen>>>
The Future of Biopharmaceutical Innovation BIO’s CEO Jim Greenwood talks about follow-on biologics and the effect of the economy on small biotechs and future biopharmaceutical innovation. Listen>>>
The Environmental Impact of Disposables Are single-use technologies bad for the environment? Listen>>>
Cell Culture Manufacturing Capacity: Outlook to 2013 (8:09) Interview with Jim Miller, president, PharmSource Information Services, and Tom Ransohoff, Senior Consultant, BioProcess Technology Consultants. Will your CMO have the capacity you need in five years? Hear the latest outlook, and learn what factors will influence that answer.
BioPharm podcasts are developed and produced by BioPharm International, a division of Advanstar
Communications, Inc., which is solely responsible for podcast content.
